Matches in Wikidata for { <http://www.wikidata.org/entity/Q91662053> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q91662053 description "article scientifique publié en 2019" @default.
- Q91662053 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91662053 description "scientific article published on 03 December 2019" @default.
- Q91662053 description "wetenschappelijk artikel" @default.
- Q91662053 description "наукова стаття, опублікована 3 грудня 2019" @default.
- Q91662053 name "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 name "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 type Item @default.
- Q91662053 label "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 label "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 prefLabel "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 prefLabel "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 P1433 Q91662053-4BE43E68-9F80-4455-9EA1-10A0A87C9391 @default.
- Q91662053 P1476 Q91662053-C0DB0473-9B84-4E66-A3E8-503D292F75E7 @default.
- Q91662053 P2093 Q91662053-3B9336C9-62C2-4ADB-A5A8-63ADF22B587D @default.
- Q91662053 P2093 Q91662053-643A4A40-4E8E-4FC3-B1DA-71F7762D94CF @default.
- Q91662053 P2093 Q91662053-A7429838-EB8C-4648-BD53-ABE1A3C8A3CA @default.
- Q91662053 P2093 Q91662053-AB4CBE26-1A03-4F13-9B1C-AE47C3C02D7E @default.
- Q91662053 P2093 Q91662053-E7172EBE-FE4D-4249-AD8F-8981F8739A11 @default.
- Q91662053 P304 Q91662053-2758AE08-A967-4D9C-83B2-E91426DBFDF7 @default.
- Q91662053 P31 Q91662053-EE172CE6-FB43-465F-A722-C28273B1C37B @default.
- Q91662053 P356 Q91662053-8C78F867-2414-4D91-89C0-5B1B551DF64B @default.
- Q91662053 P433 Q91662053-B653EFB0-5285-4E1D-8AE8-2D9499B25929 @default.
- Q91662053 P478 Q91662053-2233485B-BCC8-4AA7-94F1-908EF46B6B82 @default.
- Q91662053 P50 Q91662053-46137EB9-11D5-45AF-99FC-EBFF2B6C6A5B @default.
- Q91662053 P50 Q91662053-BCDFA573-A755-4833-8134-7F2B53732FCB @default.
- Q91662053 P577 Q91662053-58A1A9E8-4A38-48FB-B249-CDF864C1C31D @default.
- Q91662053 P698 Q91662053-27D02802-B69B-431B-A886-B758B42B9954 @default.
- Q91662053 P921 Q91662053-FF21BAA8-A482-4F39-9AE3-E48175F6A0A9 @default.
- Q91662053 P356 ACER.14228 @default.
- Q91662053 P698 31797394 @default.
- Q91662053 P1433 Q4713331 @default.
- Q91662053 P1476 "Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment" @default.
- Q91662053 P2093 "Arantza Sanvisens" @default.
- Q91662053 P2093 "Ferran Bolao" @default.
- Q91662053 P2093 "Jordi Tor" @default.
- Q91662053 P2093 "Paola Zuluaga" @default.
- Q91662053 P2093 "Xavier García-Calvo" @default.
- Q91662053 P304 "152-158" @default.
- Q91662053 P31 Q13442814 @default.
- Q91662053 P356 "10.1111/ACER.14228" @default.
- Q91662053 P433 "1" @default.
- Q91662053 P478 "44" @default.
- Q91662053 P50 Q42685946 @default.
- Q91662053 P50 Q57016359 @default.
- Q91662053 P577 "2019-12-03T00:00:00Z" @default.
- Q91662053 P698 "31797394" @default.
- Q91662053 P921 Q7331102 @default.